Growth Metrics

Pacific Biosciences Of California (PACB) Gross Profit Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 5.02%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 8.10%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 4.54%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 15.44%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 9.03%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.15%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 17.49%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 1.49%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 8.46%
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn 9.57%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 9.57%
Dec 31, 2025 47.71%
Sep 30, 2025 5.49%
Jun 30, 2025 -3.21%
Mar 31, 2025 -27.99%
Dec 31, 2024 -15.66%
Jun 30, 2024 -24.42%
Mar 31, 2024 -4.56%
Dec 31, 2023 -5.67%
Sep 30, 2023 36.34%
Jun 30, 2023 32.97%
Mar 31, 2023 9.24%
Dec 31, 2022 -26.48%
Sep 30, 2022 25.13%
Jun 30, 2022 18.98%
Mar 31, 2022 40.38%
Dec 31, 2021 42.90%
Jun 30, 2021 15.78%
Mar 31, 2021 21.16%
Dec 31, 2020 6.29%
Sep 30, 2020 -4.95%
Jun 30, 2020 -6.15%
Mar 31, 2020 -5.73%
Dec 31, 2019 4.37%
Sep 30, 2019 -18.21%
Jun 30, 2019 -3.34%
Mar 31, 2019 -18.65%
Dec 31, 2018 -39.90%
Sep 30, 2018 -21.31%
Jun 30, 2018 -15.15%
Mar 31, 2018 7.17%
Dec 31, 2017 28.85%
Sep 30, 2017 -14.50%
Jun 30, 2017 36.79%
Mar 31, 2017 49.47%
Dec 31, 2016 52.79%
Sep 30, 2016 116.75%
Jun 30, 2016 115.81%
Mar 31, 2016 117.01%
Dec 31, 2015 248.18%
Sep 30, 2015 225.48%
Jun 30, 2015 275.03%
Mar 31, 2015 244.80%
Dec 31, 2014 42.40%
Sep 30, 2014 58.14%
Jun 30, 2014 -26.58%
Mar 31, 2014 114.80%
Dec 31, 2013 124.99%
Sep 30, 2013 78.01%
Jun 30, 2013 18.96%